UB Paderborn / Katalog / Suche / in CDI

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Journal of medicinal chemistry, 1998-03, Vol.41 (7), p.1060-1067

1998

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1)

Bioorganic & medicinal chemistry, 2002, Vol.10 (1), p.31-40

2002

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of cis-4-(phosphonooxy)-2-piperidinecarboxylic acid, an N-methyl-D-aspartate antagonist

Journal of organic chemistry, 1991-06, Vol.56 (12), p.4084-4086

1991

Link zum Volltext

Verfügbarkeit prüfen

A Structure−Activity Relationship Study of Novel Phenylacetamides Which Are Sodium Channel Blockers

Journal of medicinal chemistry, 1996-03, Vol.39 (7), p.1514-1520

1996

Link zum Volltext

Verfügbarkeit prüfen

Preparation of an Autolysis-Resistant Interleukin-1β Converting Enzyme Mutant

Biochemistry (Easton), 1996-11, Vol.35 (47), p.14910-14916

1996

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (17), p.5089-5094

2010

Link zum Volltext

Verfügbarkeit prüfen

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes

Naunyn-Schmiedeberg's archives of pharmacology, 1987, Vol.335 (1), p.59-63

1987

Link zum Volltext

Verfügbarkeit prüfen

The design and synthesis of sulfonamides as caspase-1 inhibitors

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (3), p.809-812

2004

Link zum Volltext

Verfügbarkeit prüfen

An Alpha-Mercaptoacrylic Acid Derivative is a Selective Nonpeptide Cell-Permeable Calpain Inhibitor and is Neuroprotective

Proceedings of the National Academy of Sciences - PNAS, 1996-06, Vol.93 (13), p.6687-6692

1996

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex

Journal of medicinal chemistry, , Vol.36 (14), p.1977-1995

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers

Journal of medicinal chemistry, 1994-01, Vol.37 (2), p.268-274

1994

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of interteukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (17), p.5089-5094

2010

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and pharmacological evaluation of hexahydrofluorenamines as noncompetitive antagonists at the N-methyl-D-aspartate receptor

Journal of medicinal chemistry, , Vol.36 (6), p.654-670

Link zum Volltext

Verfügbarkeit prüfen

Patent Update Central & Peripheral Nervous System: Alzheimer's disease and β-amyloid: patent activity between May 1993 and June 1994

Expert opinion on therapeutic patents, 1994-10, Vol.4 (10), p.1207-1215

1994

Link zum Volltext

Verfügbarkeit prüfen

New and versatile approaches to the synthesis of CPP-related competitive NMDA antagonists. Preliminary structure activity relationships and pharmacological evaluation

Journal of medicinal chemistry, 1990-10, Vol.33 (10), p.2916-2924

1990

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic approaches to the treatment of neuroinflammatory diseases

Current pharmaceutical design, 1998-08, Vol.4 (4), p.335

Hays, S J

1998

Link zum Volltext

Verfügbarkeit prüfen

New preparations of the N-methyl-D-aspartate receptor antagonist, 4-(3-phosphonopropyl)-2-piperazinecarboxylic acid (CPP)

Tetrahedron letters, 1989, Vol.30 (39), p.5193-5196

1989

Link zum Volltext

Verfügbarkeit prüfen

Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity

Journal of pharmaceutical sciences, 1994-10, Vol.83 (10), p.1425-1432

1994

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (17), p.5089-5094

2010

Link zum Volltext

Verfügbarkeit prüfen

Section Review Central & Peripheral Nervous Systems: Alzheimer's disease and β-amyloid: patent activity between May 1995 and July 1996

Expert opinion on therapeutic patents, 1996-10, Vol.6 (10), p.1035-1046

Hays, Sheryl J

1996

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

Bioorganic & medicinal chemistry letters, 1996-03, Vol.6 (6), p.679-682

1996

Link zum Volltext

Verfügbarkeit prüfen

Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1)

Bioorganic & medicinal chemistry, 2002-01, Vol.10 (1), p.31-40

2002

Link zum Volltext

Verfügbarkeit prüfen

Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease

Bioorganic & medicinal chemistry letters, 1999-03, Vol.9 (6), p.815-820

1999

Link zum Volltext

Verfügbarkeit prüfen

2-Amino-4 H -3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Journal of medicinal chemistry, 1998-03, Vol.41 (7), p.1060-1067

1998

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of carbon-14 labeled CI-926 and CI-927, new antihypertensives

Journal of labelled compounds & radiopharmaceuticals, 1987-04, Vol.24 (4), p.351-360

Hays, Sheryl J.

1987

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

2-Amino-4H-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Structure-Based design of nonpeptide inhibitors of interleukin-1β converting enzyme (ICE, Caspase-1)

Synthesis of cis-4-(phosphonooxy)-2-piperidinecarboxylic acid, an N-methyl-D-aspartate antagonist

A Structure−Activity Relationship Study of Novel Phenylacetamides Which Are Sodium Channel Blockers

Preparation of an Autolysis-Resistant Interleukin-1β Converting Enzyme Mutant

Inhibition of interleukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes

The design and synthesis of sulfonamides as caspase-1 inhibitors

An Alpha-Mercaptoacrylic Acid Derivative is a Selective Nonpeptide Cell-Permeable Calpain Inhibitor and is Neuroprotective

Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex

Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers

Inhibition of interteukin-1β converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Synthesis and pharmacological evaluation of hexahydrofluorenamines as noncompetitive antagonists at the N-methyl-D-aspartate receptor

Patent Update Central & Peripheral Nervous System: Alzheimer's disease and β-amyloid: patent activity between May 1993 and June 1994

New and versatile approaches to the synthesis of CPP-related competitive NMDA antagonists. Preliminary structure activity relationships and pharmacological evaluation

Therapeutic approaches to the treatment of neuroinflammatory diseases

New preparations of the N-methyl-D-aspartate receptor antagonist, 4-(3-phosphonopropyl)-2-piperazinecarboxylic acid (CPP)

Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity

Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones

Section Review Central & Peripheral Nervous Systems: Alzheimer's disease and β-amyloid: patent activity between May 1995 and July 1996

Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors

Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1)

Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease

2-Amino-4 H -3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease

Synthesis of carbon-14 labeled CI-926 and CI-927, new antihypertensives

Suchergebnisse filtern